Contributions of T cell dysfunction to the resistance against anti-PD-1 therapy in oral carcinogenesis

Abstract

Our findings identified a novel mechanism that T cell dysfunction contributes to the immune resistance during the malignant transformation of the oral mucosa. This study provides new targets for improving the efficacy of immunotherapy for early stage of tumorigenesis.